Kawasaki disease refractory to initial therapy with intravenous immunoglobulin Clinical Trials

Delta Trials tracks 1 clinical trial for Kawasaki disease refractory to initial therapy with intravenous immunoglobulin in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 1 trial have reached completion. This research is carried out at 8 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.